IL86452A - Mixed crystals of insulin and insulin derivatives, a process for their preparation and pharmaceutical agents containing them - Google Patents

Mixed crystals of insulin and insulin derivatives, a process for their preparation and pharmaceutical agents containing them

Info

Publication number
IL86452A
IL86452A IL86452A IL8645288A IL86452A IL 86452 A IL86452 A IL 86452A IL 86452 A IL86452 A IL 86452A IL 8645288 A IL8645288 A IL 8645288A IL 86452 A IL86452 A IL 86452A
Authority
IL
Israel
Prior art keywords
insulin
mixed crystals
preparation
des
pharmaceutical agents
Prior art date
Application number
IL86452A
Other languages
English (en)
Other versions
IL86452A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL86452A0 publication Critical patent/IL86452A0/xx
Publication of IL86452A publication Critical patent/IL86452A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
IL86452A 1987-05-22 1988-05-20 Mixed crystals of insulin and insulin derivatives, a process for their preparation and pharmaceutical agents containing them IL86452A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717370 DE3717370A1 (de) 1987-05-22 1987-05-22 Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus

Publications (2)

Publication Number Publication Date
IL86452A0 IL86452A0 (en) 1988-11-15
IL86452A true IL86452A (en) 1993-02-21

Family

ID=6328227

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86452A IL86452A (en) 1987-05-22 1988-05-20 Mixed crystals of insulin and insulin derivatives, a process for their preparation and pharmaceutical agents containing them

Country Status (20)

Country Link
US (1) US5028587A (xx)
EP (1) EP0291863B1 (xx)
JP (1) JPS63303930A (xx)
KR (1) KR880013572A (xx)
AT (1) ATE71842T1 (xx)
AU (1) AU601280B2 (xx)
CA (1) CA1335924C (xx)
DE (2) DE3717370A1 (xx)
DK (1) DK278088A (xx)
ES (1) ES2032896T3 (xx)
FI (1) FI93797C (xx)
GR (1) GR3004344T3 (xx)
HU (1) HU203840B (xx)
IE (1) IE60649B1 (xx)
IL (1) IL86452A (xx)
NO (1) NO175641C (xx)
NZ (1) NZ224715A (xx)
PH (1) PH25587A (xx)
PT (1) PT87523B (xx)
ZA (1) ZA883599B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
DK0586589T3 (da) * 1991-05-24 1997-09-22 Amylin Pharmaceuticals Inc Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
JP4489352B2 (ja) * 2001-02-09 2010-06-23 ジェネンテック， インコーポレイテッド Ｉｇｆ−１の結晶化
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
KR20090091321A (ko) * 2006-11-28 2009-08-27 마리누스 파마슈티컬스 나노입자 제형, 이의 제조방법 및 이의 용도
WO2015084694A2 (en) 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
US10124040B2 (en) 2014-08-26 2018-11-13 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin or insulin analog compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
EG12098A (en) * 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
KR880013572A (ko) 1988-12-21
FI93797B (fi) 1995-02-28
NO175641B (xx) 1994-08-01
HUT46546A (en) 1988-11-28
NO882207D0 (no) 1988-05-20
EP0291863B1 (de) 1992-01-22
PH25587A (en) 1991-08-08
AU1648788A (en) 1988-11-24
DE3867903D1 (de) 1992-03-05
NO882207L (no) 1988-11-23
HU203840B (en) 1991-10-28
DE3717370A1 (de) 1988-12-01
ZA883599B (en) 1989-01-25
FI93797C (fi) 1995-06-12
GR3004344T3 (xx) 1993-03-31
FI882354A0 (fi) 1988-05-19
EP0291863A2 (de) 1988-11-23
ES2032896T3 (es) 1993-03-01
NO175641C (no) 1994-11-09
IL86452A0 (en) 1988-11-15
EP0291863A3 (en) 1990-04-04
JPS63303930A (ja) 1988-12-12
IE60649B1 (en) 1994-08-10
PT87523A (pt) 1989-05-31
IE881522L (en) 1988-11-22
US5028587A (en) 1991-07-02
FI882354A (fi) 1988-11-23
AU601280B2 (en) 1990-09-06
CA1335924C (en) 1995-06-13
PT87523B (pt) 1992-09-30
DK278088D0 (da) 1988-05-20
NZ224715A (en) 1990-04-26
DK278088A (da) 1988-11-23
ATE71842T1 (de) 1992-02-15

Similar Documents

Publication Publication Date Title
IL86452A (en) Mixed crystals of insulin and insulin derivatives, a process for their preparation and pharmaceutical agents containing them
IL82209A0 (en) Insulin preparation
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
HUT51138A (en) Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine
YU101385A (en) Process for obtaining crystal calcium pseudomonate or its hydrate
DK617086D0 (da) Antibiotikum a 40926 mannosyl-aglycon og additionssalte deraf samt laegemiddel indeholdende en saadan forbindelse
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
HUT47425A (en) Process for producing pharmaceutical compositions for treating diabetes mellitus
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
JPS645460A (en) Production of delaying gelatinous material
HU905853D0 (en) Process for the preparation of medical products containing dopamine-autoreceptor-antagonists for treating drug dependence
HUT46904A (en) Process for production of derivatives of 1,3,5-tritian and medical compounds containing such substances
UA8036A1 (uk) Спосіб одержання похідних тіазолу або їх кислотно-аддітивних солей
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона
NZ226237A (en) Choline diethyl-dithiocarbamate, process for the preparation thereof, and medicaments
EG19461A (en) Process for preparing of s-substituted betathioacrylamides and their use as microbicide.
HU9201315D0 (en) Process for the production of medical preparations containing 4-/n,n-dibenzyl-amino/-butyric acid or butyric amid as active agent, or their medically useful salts